Regencell Bioscience's total assets for Q0 0 were $12.62M, a decrease of -29.95% from the previous quarter. RGC total liabilities were $632.32K for the fiscal quarter, a -32.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.